AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

United States Vaccines Market Report 2019: Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecasts, 2015-2018 & 2019-2026 - ResearchAndMarkets.com

November 5, 2019

DUBLIN--(BUSINESS WIRE)--Nov 5, 2019--

The “United States Vaccines Market Size, Share, Growth Opportunities, Future Trends, Top Key Players, and Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.

The United States vaccines market is poised to reach a value of more than US$ 26 billion by 2026.

The report offers the most up-to-date industry data on the actual market situation and future outlook for the united states vaccines market. The report provides historical market data for 2015 - 2018, and forecasts from 2019 till 2026.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026. The report provides clear insight into current and future developments of the united states vaccines market.

The report also explores the detailed analysis of the leading 27 vaccine market assessments in the United States from 2015 to 2018 and forecasts to 2026. A comprehensive analysis has been done on market share with a percentage of the leading 27 vaccines. The report also details the latest information about the vaccine’s pricing trends and the regulatory framework of the United States vaccine market.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2026.

The report concludes with the profiles of the key players in the united states vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in clinical development, and recent development.

Key Topics Covered in the Report:

The Report Helps Answer the Following Questions:

Key Topics Covered:

1. Executive Summary

2. United States Vaccines Market Size & Forecast (2015 - 2026)

3. United States Vaccines Market Share & Y-o-Y Growth (%), 2017 - 2026

4. United States Vaccines Market - Key Market Dynamics

4.1 Key Market Drivers

4.2 Key Market Inhibitors

5. United States Leading 27 Vaccines Market Assessment & Opportunity (Value), 2015 - 2026

5.1 Prevnar/Prevnar 13

5.2 Gardasil/Gardasil 9

5.3 Fluzone

5.4 Flublok

5.5 Flucelvax Quadrivalent

5.6 Afluria Quadrivalent

5.7 Fluad

5.8 Varivax

5.9 Menactra

5.10 Proquad

5.11 Pneumovax 23

5.12 Fluarix/FluLaval

5.13 Havrix/Twinrix/Engerix-B

5.14 M-M-R II

5.15 Adacel

5.16 Boostrix

5.17 Bexsero

5.18 Menveo

5.19 Trumenba

5.20 Shingrix

5.21 Pentacel

5.22 Recombivax HB

5.23 Rotateq

5.24 Rotarix

5.25 Pediarix/Infanrix

5.26 Heplisav-B

5.27 TDVAX

5.28 Other Vaccines

6. United States Vaccines Pricing Trends & Analysis

7. Regulatory Framework of the United States Vaccines Market

8. Major Deals and Agreement Happenings in the Vaccines Market

8.1 Collaboration Deal

8.2 Licensing Agreement

8.3 Exclusive Agreement

8.4 Distribution Agreement

8.5 Partnerships

9. Key Players in the United States Vaccines Market

9.1 Sanofi Pasteur

9.1.1 Business Overview

9.1.2 Promising Vaccines in the Clinical Development

9.1.3 Recent Development

9.2 GlaxoSmithKline (GSK)

9.3 Merck

9.4 Pfizer

9.5 Dynavax Technologies Corporation

9.6 Grifols

For more information about this report visit https://www.researchandmarkets.com/r/ckl2fk

View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005659/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HOSPITALS GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/05/2019 08:02 AM/DISC: 11/05/2019 08:02 AM

http://www.businesswire.com/news/home/20191105005659/en